Long lasting response with trabectedin monotherapy in relapsed metastatic mesenchymal chondrosarcoma
ConclusionThis report aims to present a comprehensive review into available and newer treatment choices for mesenchymal chondrosarcoma, and to highlight trabectedin monotherapy as a possible therapeutic option for mesenchymal chondrosarcoma in the relapsed setting.
Source: Clinical Sarcoma Research - Category: Cancer & Oncology Source Type: research
More News: Cancer & Oncology | Chemotherapy | Chondrosarcoma | Clinical Trials | Pain | Pain Management | Palliative | Sarcomas | Translocation